
Takeda Pharmaceutical Company Limited TAK
€ 15.80
-1.04%
Quartalsbericht 2022-Q1
hinzugefügt 29.06.2022
Takeda Pharmaceutical Company Limited DIO 2011-2026 | TAK
DIO Jährlich Takeda Pharmaceutical Company Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 254 | 546 | 157 | 148 | 173 | 184 | 189 | 187 | 164 | 158 |
Alle Zahlen in JPY-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 546 | 148 | 216 |
DIO anderer Aktien in der Pharmaeinzelhändler
| Name | DIO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Acasti Pharma
ACST
|
136 | - | 4.01 % | $ 150 M | ||
|
Aptorum Group Limited
APM
|
4.89 | $ 0.81 | 1.31 % | $ 4.42 M | ||
|
Axsome Therapeutics
AXSM
|
168 | $ 167.61 | -4.09 % | $ 8.34 B | ||
|
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
BioMarin Pharmaceutical
BMRN
|
736 | $ 63.02 | 0.15 % | $ 12 B | ||
|
CASI Pharmaceuticals
CASI
|
47.4 | $ 0.79 | 4.29 % | $ 108 M | ||
|
Catalyst Biosciences
CBIO
|
410 | $ 12.71 | 10.81 % | $ 837 M | ||
|
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | ||
|
Amneal Pharmaceuticals
AMRX
|
123 | $ 14.72 | 2.08 % | $ 4.55 B | ||
|
Arena Pharmaceuticals
ARNA
|
160 | - | -6.81 % | $ 3.04 B |